A Review of the Impact of Sociodemographic Factors on the Assessment and Management of Pediatric Somatic Symptom and Related Disorders.
Autor: | Kline CL; Department of Psychiatry, University of Michigan, Ann Arbor, MI. Electronic address: klinech@umich.edu., Shamshair S; Department of Psychiatry, University of Michigan, Ann Arbor, MI., Kullgren KA; Department of Pediatrics, C.S. Mott Children's Hospital, Ann Arbor, MI., Leber SM; Department of Neurology, Ann Arbor, MI., Malas N; Department of Psychiatry, University of Michigan, Ann Arbor, MI. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of the Academy of Consultation-Liaison Psychiatry [J Acad Consult Liaison Psychiatry] 2023 Jan-Feb; Vol. 64 (1), pp. 58-64. Date of Electronic Publication: 2022 Nov 01. |
DOI: | 10.1016/j.jaclp.2022.10.266 |
Abstrakt: | Background: While factors such as race, sex, gender identity, and socioeconomic status impact the diagnosis and treatment of a variety of conditions, there are few studies examining their influence on somatic symptom and related disorders (SSRDs), particularly in the pediatric population. Objective: In this review, we outline the existing literature on how sociodemographic characteristics influence the overall care of pediatric SSRDs. Throughout this literature review, we highlight opportunities for further research, including potential disparities in evaluation, management, and outcomes along several sociodemographic domains. Methods: We conducted a thorough review of the evidence for potential impact of race, sex, gender identity, and socioeconomic status on the presentation, diagnosis, management, and outcomes of pediatric somatization and SSRDs. Results: Recent studies evaluating the impact of race on SSRD care suggest the potential for provider bias in the evaluation and management of this population based on racial differences in diagnostic evaluations. Somatization may present differently based on a patient's race and potential cross-cultural status. Among studies of cisgender patients, there is evidence of provider bias in the assessment of somatic symptoms such that female patients are more likely to be diagnosed with an SSRD than male patients. However, there is little research among youth identifying as LGBTQ. The literature also indicates that low socioeconomic status and associated stressors are linked with the development of SSRDs, although it is unclear whether these factors are subject to bias by providers. Conclusions: While the literature is sparse, there is evidence that sociodemographic factors contribute to differences in diagnosis, evaluation, and management of pediatric SSRDs. These factors, particularly race and sex, may also be subject to provider bias, although further studies are necessary. Provider bias can directly impact patients' perception of care, including feelings of dismissal, and may have downstream influences on symptom manifestation, patient-provider engagement, diagnostic evaluation, and management practices. (Published by Elsevier Inc.) |
Databáze: | MEDLINE |
Externí odkaz: |